Cumberland Pharmaceuticals Amends Nuvo Asset Sale Agreement Ahead of $100 Million Transaction Close
Cumberland Pharmaceuticals refined the terms of its asset divestiture by signing Amendment No. 1 to the Asset Purchase Agreement with Nuvo on July 1, 2026, excluding certain contracts from the assets transferred. In connection with the closing, the company also terminated its Revolving Credit Loan…